Today: 5 June 2026
Browse Category

Artificial Intelligence 6 March 2023 - 2 February 2024

Zebra Medical Vision’s AI Reads Medical Images. Now Comes the Hospital Test

Zebra Medical Vision’s AI Reads Medical Images. Now Comes the Hospital Test

Nanox.AI, formerly Zebra Medical Vision, is now the imaging software unit of Nasdaq-listed Nanox, which acquired Zebra for $100 million in 2021. The company reported losses and financing risk in its 2026 filing but said it added Cedars-Sinai as a trial partner and accelerated U.S. deployment of its Nanox.ARC systems. NICE approved Nanox AI tools for NHS use during a three-year evidence period. FDA cleared its HealthFLD liver analysis software in 2024.
2 February 2024
·
AI Layoffs in 2023: The Real Number Was 4,247, and the Next Wave Is Harder to Count

AI Layoffs in 2023: The Real Number Was 4,247, and the Next Wave Is Harder to Count

U.S. employers cited artificial intelligence in 4,247 announced job cuts in 2023, according to Challenger, Gray & Christmas. By March 2026, AI was the top stated reason for U.S. job cuts that month, with 15,341 announced. The broader labor market showed 6.866 million job openings in March 2026, while layoffs remained at 1.2%, according to the Labor Department.
6 March 2023
···
1 … 202 203 204

Stock Market Today

  • Alvotech Shares Surge 19% on FDA Biosimilar Resubmission
    June 5, 2026, 3:29 PM EDT. Alvotech's stock jumped 19% following the resubmission of biologics license applications (BLAs) to the U.S. FDA for biosimilars AVT05 and AVT06. AVT05 targets chronic inflammatory diseases as a biosimilar to Simponi, while AVT06 treats retinal diseases as a biosimilar to Eylea. Both drugs are developed with Teva Industries, which holds commercialization rights. Earlier, the FDA issued a Complete Response Letter on AVT05 citing manufacturing issues, not product safety. Alvotech responded with improved manufacturing protocols and expects FDA review within six months. Despite this, Alvotech shares are down 27.1% year-to-date against a 1.1% industry decline, with a Zacks Rank hold rating.

Latest articles

Valens Semiconductor Drops 38% as Chip Stocks Slide

Valens Semiconductor Drops 38% as Chip Stocks Slide

5 June 2026
Valens Semiconductor shares crashed 38% to $2.00 on record volume after May U.S. payrolls surged, sparking a broad chip stock selloff and sector-wide valuation reset, despite Valens’ Q1 revenue beating guidance and analysts holding a mean “buy” rating with a $4.333 target before the rout.
AMD Stock Slumps as AI Chip Trade Meets a Jobs-Report Shock

AMD Stock Slumps as AI Chip Trade Meets a Jobs-Report Shock

5 June 2026
Lider Electric’s LN-1450RH and LN-1450RHW NEMA 14-50 receptacles received UL certification with Electric Vehicle Marking, targeting the fast-growing home EV charging market as private light-duty vehicle charging points topped 43 million in 2025, but the crowded field and installation requirements pose challenges for adoption.
Go toTop